Refirm Tablet

Overview Refirm Tablet

Refirm Tablets offer nutritional support for menopausal symptoms, combining Ipriflavone, calcium, and alfacalcidol. Ipriflavone, a synthetic isoflavone derived from soy, counteracts bone loss by reducing osteoclast activity. Alfacalcidol (vitamin D3) optimizes calcium absorption in the gut and minimizes kidney calcium excretion, crucial for bone health and fracture prevention, particularly in osteoporosis. Studies indicate that ipriflavone and vitamin D synergistically combat postmenopausal bone loss more effectively than either component alone. Calcium, vital for nerve, cell, muscle, and bone function, prevents bone weakening from calcium depletion. Refirm Tablets thus support bone health by promoting bone formation and inhibiting osteoclast activity, offering a non-hormonal, non-estrogenic approach. Recommended for peri- and postmenopausal osteoporosis, senile osteoporosis, and osteoporosis induced by medication. Dosage: One to two tablets daily, under medical guidance.